Biotech · Private company
Arbor Biotechnologies
Track this companyFree. Adds Arbor Biotechnologies to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ABO-101Phase 2 · Primary Hyperoxaluria Type 1 (PH1)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)PHASE1_PHASE2 · RECRUITING · started Jun 16, 2025ClinicalTrials.gov NCT06839235 · fetched Nov 12, 2026